Tahoe Therapeutics Funding: $42M Raised, Series A (2025)
Tahoe Therapeutics is based in Palo Alto, California. It has raised $42M in total funding. Latest round: Series A.
Tahoe Therapeutics funding overview
Tahoe Therapeutics is based in Palo Alto, California. Tahoe Therapeutics has raised $42M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in August 2025. The round record for Tahoe Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Amplify Partners, Databricks Ventures, Wing Venture Capital, General Catalyst, AIX Ventures, Civilization Ventures and 2 others. 8 distinct backers are named across the disclosed rounds.
Tahoe Therapeutics at a glance
Total raised
$42M
Latest round
Series A
Latest round date
August 2025
Headquarters
Palo Alto, California
Notable investors
Amplify Partners, Databricks Ventures, Wing Venture Capital, General Catalyst, AIX Ventures, Civilization Ventures, Conviction, Mubadala Capital
Frequently asked about Tahoe Therapeutics funding
How much has Tahoe Therapeutics raised?
Tahoe Therapeutics has raised $42M in total disclosed funding across the rounds on record.
Who has invested in Tahoe Therapeutics?
Amplify Partners, Databricks Ventures, Wing Venture Capital, General Catalyst, AIX Ventures, Civilization Ventures are named among the investors backing Tahoe Therapeutics.
What was the latest Tahoe Therapeutics funding round?
The most recent disclosed round is a Series A, announced in August 2025.
Where is Tahoe Therapeutics based?
Tahoe Therapeutics is based in Palo Alto, California.
When did Tahoe Therapeutics last raise?
The last disclosed Tahoe Therapeutics round closed in August 2025 at Series A.
We update the Tahoe Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Palo Alto and their backers are listed below.
